These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38633121)

  • 21. ETV6-RUNX1
    Ford AM; Greaves M
    Adv Exp Med Biol; 2017; 962():217-228. PubMed ID: 28299660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical features and prognostic analysis of testicular relapse in pediatric acute lymphoblastic leukemia].
    Wang N; Gao YY; Qi BQ; Ruan M; Lyu H; Zhang XY; Zhang RR; Liu TF; Chen YM; Zou Y; Guo Y; Yang WY; Zhang L; Zhu XF; Chen XJ
    Zhonghua Er Ke Za Zhi; 2024 Mar; 62(3):262-267. PubMed ID: 38378289
    [No Abstract]   [Full Text] [Related]  

  • 23. Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia.
    Forero-Castro M; Robledo C; Benito R; Bodega-Mayor I; Rapado I; Hernández-Sánchez M; Abáigar M; Maria Hernández-Sánchez J; Quijada-Álamo M; María Sánchez-Pina J; Sala-Valdés M; Araujo-Silva F; Kohlmann A; Luis Fuster J; Arefi M; de Las Heras N; Riesco S; Rodríguez JN; Hermosín L; Ribera J; Camos Guijosa M; Ramírez M; de Heredia Rubio CD; Barragán E; Martínez J; Ribera JM; Fernández-Ruiz E; Hernández-Rivas JM
    Br J Cancer; 2017 Jul; 117(2):256-265. PubMed ID: 28557976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SYK Targeting Represents a Potential Therapeutic Option for Relapsed Resistant Pediatric
    Serafin V; Porcù E; Cortese G; Mariotto E; Veltri G; Bresolin S; Basso G; Accordi B
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Prognostic Effect of
    Østergaard A; Enshaei A; Pieters R; Vora A; Horstmann MA; Escherich G; Johansson B; Heyman M; Schmiegelow K; Hoogerbrugge PM; den Boer ML; Kuiper RP; Moorman AV; Boer JM; van Leeuwen FN
    Hemasphere; 2023 May; 7(5):e875. PubMed ID: 37153875
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of ETV6/RUNX1 Fusion and Additional Abnormalities Involving ETV6 and/or RUNX1 Genes Using FISH Technique in Patients with Childhood Acute Lymphoblastic Leukemia.
    Aydin C; Cetin Z; Manguoglu AE; Tayfun F; Clark OA; Kupesiz A; Akkaya B; Karauzum SB
    Indian J Hematol Blood Transfus; 2016 Jun; 32(2):154-61. PubMed ID: 27065576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia.
    Krentz S; Hof J; Mendioroz A; Vaggopoulou R; Dörge P; Lottaz C; Engelmann JC; Groeneveld TW; Körner G; Seeger K; Hagemeier C; Henze G; Eckert C; von Stackelberg A; Kirschner-Schwabe R
    Leukemia; 2013 Feb; 27(2):295-304. PubMed ID: 22699455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol.
    Cario G; Rhein P; Mitlöhner R; Zimmermann M; Bandapalli OR; Romey R; Moericke A; Ludwig WD; Ratei R; Muckenthaler MU; Kulozik AE; Schrappe M; Stanulla M; Karawajew L
    Haematologica; 2014 Jan; 99(1):103-10. PubMed ID: 23911702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene Expression Profiling of Acute Lymphoblastic Leukemia in Children with Very Early Relapse.
    Núñez-Enríquez JC; Bárcenas-López DA; Hidalgo-Miranda A; Jiménez-Hernández E; Bekker-Méndez VC; Flores-Lujano J; Solis-Labastida KA; Martínez-Morales GB; Sánchez-Muñoz F; Espinoza-Hernández LE; Velázquez-Aviña MM; Merino-Pasaye LE; García Velázquez AJ; Pérez-Saldívar ML; Mojica-Espinoza R; Ramírez-Bello J; Jiménez-Morales S; Mejía-Aranguré JM;
    Arch Med Res; 2016 Nov; 47(8):644-655. PubMed ID: 28476192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of lncRNA-mRNA co-expression network in ETV6-RUNX1-positive pediatric B-cell acute lymphoblastic leukemia.
    Yu W; Wang W; Yu X
    PLoS One; 2021; 16(6):e0253012. PubMed ID: 34101758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coexistence of
    Qiu KY; Liao XY; Huang K; Xu HG; Li Y; Zhou DH; Fang JP
    Transl Cancer Res; 2023 Oct; 12(10):2952-2958. PubMed ID: 37969368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ETV6/RUNX1 fusion at diagnosis and relapse: some prognostic indications.
    Martineau M; Jalali GR; Barber KE; Broadfield ZJ; Cheung KL; Lilleyman J; Moorman AV; Richards S; Robinson HM; Ross F; Harrison CJ
    Genes Chromosomes Cancer; 2005 May; 43(1):54-71. PubMed ID: 15704129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ETV6/RUNX1-positive childhood acute lymphoblastic leukemia (ALL): The spectrum of clonal heterogeneity and its impact on prognosis.
    Ampatzidou M; Papadhimitriou SI; Paterakis G; Pavlidis D; Tsitsikas Κ; Kostopoulos IV; Papadakis V; Vassilopoulos G; Polychronopoulou S
    Cancer Genet; 2018 Aug; 224-225():1-11. PubMed ID: 29778230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autophagy inhibition as a potential future targeted therapy for ETV6-RUNX1-driven B-cell precursor acute lymphoblastic leukemia.
    Polak R; Bierings MB; van der Leije CS; Sanders MA; Roovers O; Marchante JRM; Boer JM; Cornelissen JJ; Pieters R; den Boer ML; Buitenhuis M
    Haematologica; 2019 Apr; 104(4):738-748. PubMed ID: 30381299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD9 predicts ETV6-RUNX1 in childhood B-cell precursor acute lymphoblastic leukemia.
    Blunck CB; Terra-Granado E; Noronha EP; Wajnberg G; Passetti F; Pombo-de-Oliveira MS; Emerenciano M
    Hematol Transfus Cell Ther; 2019; 41(3):205-211. PubMed ID: 31085145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single cell characterization of B-lymphoid differentiation and leukemic cell states during chemotherapy in ETV6-RUNX1-positive pediatric leukemia identifies drug-targetable transcription factor activities.
    Mehtonen J; Teppo S; Lahnalampi M; Kokko A; Kaukonen R; Oksa L; Bouvy-Liivrand M; Malyukova A; Mäkinen A; Laukkanen S; Mäkinen PI; Rounioja S; Ruusuvuori P; Sangfelt O; Lund R; Lönnberg T; Lohi O; Heinäniemi M
    Genome Med; 2020 Nov; 12(1):99. PubMed ID: 33218352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defining low-risk high hyperdiploidy in patients with paediatric acute lymphoblastic leukaemia: a retrospective analysis of data from the UKALL97/99 and UKALL2003 clinical trials.
    Enshaei A; Vora A; Harrison CJ; Moppett J; Moorman AV
    Lancet Haematol; 2021 Nov; 8(11):e828-e839. PubMed ID: 34715050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discontinuation of L-asparaginase and poor response to prednisolone are associated with poor outcome of ETV6-RUNX1-positive pediatric B-cell precursor acute lymphoblastic leukemia.
    Usami I; Imamura T; Takahashi Y; Suenobu SI; Hasegawa D; Hashii Y; Deguchi T; Hori T; Shimada A; Kato K; Ito E; Moriya-Saito A; Kawasaki H; Hori H; Yumura-Yagi K; Hara J; Sato A; Horibe K;
    Int J Hematol; 2019 Apr; 109(4):477-482. PubMed ID: 30689137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Landscape of Secondary Genetic Rearrangements in Pediatric Patients with B-Cell Acute Lymphoblastic Leukemia with t(12;21).
    Kaczmarska A; Derebas J; Pinkosz M; Niedźwiecki M; Lejman M
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of ETV6/RUNX1-positive childhood acute lymphoblastic leukaemia in the NOPHO-ALL-1992 protocol: frequent late relapses but good overall survival.
    Forestier E; Heyman M; Andersen MK; Autio K; Blennow E; Borgström G; Golovleva I; Heim S; Heinonen K; Hovland R; Johannsson JH; Kerndrup G; Nordgren A; Rosenquist R; Swolin B; Johansson B; ; ;
    Br J Haematol; 2008 Mar; 140(6):665-72. PubMed ID: 18241254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.